Hypermethylation of E-cadherin and estrogen receptor-α gene promoter and its association with clinicopathological features of breast cancer in Iranian patients

Iranian Journal of Medical Sciences

Volumn 34, Issue 3, 2009, Pages 186-192

  Rasti, Mozhgan ^a   Entezam, Mona ^b   Monabati, Ahmad ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY   (Iran)

Author keywords

Breast cancer; CDH1; CpG island; ESR ; Methylation

Indexed keywords

DNA; ESTROGEN RECEPTOR ALPHA; UVOMORULIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INVASION; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; GENE LOCUS; HUMAN; METHYLATION; POLYMERASE CHAIN REACTION; PRIMARY TUMOR; TUMOR VOLUME;

EID: 67749091262     PISSN: 02530716     EISSN: 17353688     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Rajaeifard A.A.R, Talei A, Baneshi M. Survival analysis models for breast cancer patients in Shiraz, 1993-2002. JMR 2005; 3: 41-50.
2. Miremadi A, Oestergaard MZ, Pharoah PD, et al. Cancer genetics of epigenetic genes. Hum Mol Genet 2007; 16 Spec No 1: R28-R49.
3. Luczak MW, Jagodziński PP. The role of DNA methylation in cancer development. Folia Histochem Cytobiol 2006; 44: 143-154 (Pubitemid 44131981)
4. Bird AP. DNA methylation and the frequency of CpG in animal DNA. Nucleic Acids Res 1980; 8: 1499-1504
5. Cross SH, Bird AP. CpG islands and genes. Curr Opin Genet Dev 1995; 5: 309-314
6. Yang X, Yan L, Davidson NE. DNA methylation in breast cancer. Endocrine-Related Cancer 2001; 8: 115-127
7. Naqvi RA, Hussain A, Deo SS, et al. Hypermethylation analysis of mismatch repair genes (hmlh1 and hmsh2) in locally advanced breast cancers in Indian women. Human pathology 2008; 39: 672-680
8. Zhao L, Wang L, Jin F, et al. Silencing of estrogen receptor alpha (ERalpha) gene by promoter hypermethylation is a frequent event in Chinese women with sporadic breast cancer. Breast Cancer Res Treat 2008.
9. Tao MH, Shields PG, Nie J, et al. DNA hypermethylation and clinicopathological features in breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study. Breast Cancer Res Treat 2009; 114: 559-568
10. Parrella P, Poeta ML, Gallo AP, et al. Nonrandom distribution of aberrant promoter methylation of cancer-related genes in sporadic breast tumors. Clin Cancer Res 2004; 10: 5349-5354 (Pubitemid 39100470)
11. Overduin M, Harvey TS, Bagby S, et al. Solution structure of the epithelial cadherin domain responsible for selective cell adhesion. Science 1995; 267: 386-389
12. Caldeira JR, Prando EC, Quevedo FC, et al. CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer. BMC Cancer 2006; 6: 48.
13. Sunami E, Shinozaki M, Sim MS, et al. Estrogen receptor and HER2/neu status affect epigenetic differences of tumorrelated genes in primary breast tumors. Breast Cancer Res 2008; 10: R46.
14. Keen JC, Davidson NE. The biology of breast carcinoma. Cancer 2003; 97: 825-833
15. Lapidus RG, Nass SJ, Davidson NE. The loss of estrogen and progesterone receptor gene expression in human breast cancer. J Mammary Gland Biol Neoplasia 1998; 3: 85-94. (Pubitemid 128513222)
16. Lapidus RG, Ferguson AT, Ottaviano YL, et al. Methylation of estrogen and progesterone receptor gene 5' CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors. Clin Cancer Res 1996; 2: 805-810 (Pubitemid 26168932)
17. Ottaviano YL, Issa JP, Parl FF, et al. Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. Cancer Res 1994; 54: 2552-2555 (Pubitemid 24173735)
18. Nass SJ, Herman JG, Gabrielson E, et al. Aberrant methylation of the estrogen receptor and E-cadherin 5' CpG islands increases with malignant progression in human breast cancer. Cancer Res 2000; 60:4346-4348 (Pubitemid 32103608)
19. Tan SH, Ida H, Lau QC, et al. Detection of promoter hypermethylation in serum samples of cancer patients by methylationspecific polymerase chain reaction for tumour suppressor genes including RUNX3. Oncol Rep 2007; 18:1225-1230
20. Mirza S, Sharma G, Prasad CP, et al. Promoter hypermethylation of TMS1, BRCA1, ERalpha and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients. Life Sci 2007; 81: 280-287 (Pubitemid 47030571)
21. Esteler M. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene 2002; 21: 5427-5440
22. Evron E, Dooley WC, Umbricht CB, et al. Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR. Lancet 2001; 357: 1335-1336 (Pubitemid 32441534)
23. Krassenstein R, Sauter E, Dulaimi E, et al. Detection of breast cancer in nipple aspirate fluid by CpG island hypermethylation. Clin Cancer Res 2004; 10: 28-32. (Pubitemid 38114158)
24. Spector D, Goldman R, Leinwand L. Cells: A Laboratory Manual (Culture and Biochemical Analysis of Cells) Vol 1. Cold Spring Harbor Laboratory Press, 1998.
25. Herman JG, Graff JR, Myöhänen S, et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996; 93: 9821-9826 (Pubitemid 26296693)
26. Graff JR, Herman JG, Myohanen S, et al. Mapping patterns of CpG island methylation in normal and neoplastic cells implicates both upstream and downstream regions in de novo methylation. J Biol Chem 1997; 272: 22322-22329 (Pubitemid 27382868)
27. Lapidus RG, Nass SJ, Butash KA, et al. Mapping of ER gene CpG island methylation- specific polymerase chain reaction. Cancer Res 1998; 58: 2515-2519
28. Agrawal A, Murphy RF, Agrawal DK. DNA methylation in breast and colorectal cancers. Mod Pathol 2007; 20: 711-721 (Pubitemid 46933450)
29. Li S, Rong M, Iacopetta B. DNA hypermethylation in breast cancer and its association with clinicopathological features. Cancer Lett 2006; 237: 272-280 (Pubitemid 43792523)
30. Kim SJ, Kim TW, Lee SY, et al. CpG methylation of the ERalpha and ERbeta genes in breast cancer. Int J Mol Med 2004; 14: 289-293
31. Lostumbo A, Mehta D, Setty S, Nunez R. Flow cytometry: a new approach for the molecular profiling of breast cancer. Exp Mol Pathol 2006; 80: 46-53. (Pubitemid 41828226)
32. Pećina-Slaus N. Tumor suppressor gene E-cadherin and its role in normal and malignant cells. Cancer Cell Int 2003; 3:17. (Pubitemid 38751068)
33. Conacci-Sorrell M, Zhurinsky J, Ben-Ze'ev A. The cadherin-catenin adhesion system in signaling and cancer. J Clin Invest 2002; 109: 987-991 (Pubitemid 34408571)
34. Yoshida T, Eguchi H, Nakachi K, et al. Distinct mechanisms of loss of estrogen receptor alpha gene expression in human breast cancer: methylation of the gene and alteration of trans-acting factors. Carcinogenesis 2000; 21: 2193-2201 (Pubitemid 32049225)
35. Dahlman-Wright K, Cavailles V, Fuqua SA, et al. International Union of Pharmacology. LXIV. Estrogen receptors. Pharmacol Rev 2006; 58: 773-781 (Pubitemid 44833745)